Discover 928 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 928
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
for
Amyloidosis, Transthyretin Amyloidosis
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 40 - 70+
Code: NCT05758493
Phase 2, Recruiting
Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus
for
Diabetes Mellitus
Location: Portland OR, Santa Barbara CA, Aurora CO, New York NY,
Sponsor: DexCom, Inc.
Sex: Female
Age: 18+
Code: NCT04905628
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Portland OR, Salt Lake City UT, Los Angeles CA,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06619561
Phase 2, Recruiting
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
for
Biochemically Recurrent Prostate Carcinoma,
Location: Portland OR, Clackamas OR, Vancouver WA, Oregon City OR,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: Male
Age: 18+
Code: NCT04423211
Phase 3, Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Sex: All
Age: 18+
Code: NCT04031677
Phase 3, Recruiting
CGM for Management of Type 2 Diabetes in Pregnancy
for
Type 2 Diabetes Mellitus (T2DM), Pregnancy
Location: Portland OR, San Diego CA, Houston TX, Birmingham AL,
Sponsor: University of Alabama at Birmingham
Sex: Female
Age: 18 - 50
Code: NCT06628453
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Portland OR, Olympia WA, Spokane WA, Reno NV,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05947851
Phase 3, Recruiting
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
for
B Acute Lymphoblastic Leukemia Associated With Down Syndrome,
Location: Portland OR, Surrey, Loma Linda CA, Long Beach CA,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0 - 1
Code: NCT05685745
Recruiting
Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygiene System
for
Surgical Wound Infection, Cross Infection
Location: Portland OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 18 - 70+
Code: NCT04900298
Recruiting
ATLAS (AltaValve) Pivotal Trial
for
Mitral Regurgitation, Mitral Insufficiency,
Location: Portland OR, Seattle WA, Vancouver, San Francisco CA,
Sponsor: 4C Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT06465745
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Portland OR, Vancouver WA, Seattle WA, Edmonds WA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase 3, Recruiting
Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
for
Smith-Lemli-Opitz Syndrome
Location: Portland OR
Sponsor: National Center for Research Resources (NCRR)
Sex: All
Age: 0+
Code: NCT00004347
Phase 2, Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma